<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37816180</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1092-4221</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>International journal of pharmaceutical compounding</Title><ISOAbbreviation>Int J Pharm Compd</ISOAbbreviation></Journal><ArticleTitle>Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment.</ArticleTitle><Pagination><StartPage>368</StartPage><EndPage>380</EndPage><MedlinePgn>368-380</MedlinePgn></Pagination><Abstract><AbstractText>The effects of infection with the&#xa0;highly transmissible severe acute&#xa0;respiratory syndrome coronavirus&#xa0;2 (SARS-CoV-2) and the coronavirus-&#xa0;disease-2019 (COVID-19)&#xa0;it engenders continue to demonstrate&#xa0;that worldwide, the&#xa0;detection, prediction, and control&#xa0;of novel-pathogen pandemics&#xa0;remain largely unattained&#xa0;achievements. Key to successfully&#xa0;meeting those goals is a thorough&#xa0;understanding of the mechanisms&#xa0;of evolving causative agents and&#xa0;effective prophylaxis against&#xa0;them. In this article, we review&#xa0;common conditions that afflict&#xa0;people with COVID-19 or long&#xa0;COVID, examine the effectiveness&#xa0;of vaccines designed to prevent&#xa0;infection with SARS-CoV-2 and&#xa0;mitigate its sequelae, and provide&#xa0;formulations for 2 compounded&#xa0;preparations that can assist recovery&#xa0;from acute and chronic conditions&#xa0;caused by that virus when&#xa0;manufactured drugs are unavailable&#xa0;in required dosages or dosage&#xa0;forms or cannot be tolerated&#xa0;by the patient.</AbstractText><CopyrightInformation>Copyright&#xa9; by International Journal of Pharmaceutical Compounding, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Riepl</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Retired Compounding Pharmacist, Bismarck, North Dakota. flintlock@bis.midco.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiser</LastName><ForeName>Joe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Dakota PrecisionRx Labs in Bismarck, North Dakota. joe@precisionrxlabs.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Pharm Compd</MedlineTA><NlmUniqueID>9706294</NlmUniqueID><ISSNLinking>1092-4221</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37816180</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>